6th Annual Clinical Data Integration and Management 201721st – 22nd March 2017
Following the success of our 2016 event, Arena International are pleased to announce the dates for the 6th Clinical Data Integration and Management conference. Bringing together senior level professionals working with data in clinical trials – this 2 day event provides a platform to network and hear thought leadership on the current trends on managing data.
In 2016 over 120 attendees joined interactive sessions, roundtables, innovative presentations and had an opportunity to network with their peers to discuss the industry’s biggest challenges. Our 2017 agenda will include challenges with data visualisation, risk based monitoring, working with vendors and also looking at current technological trends in data management.
We look forward to seeing you in Princeton on 21st – 22nd March 2017..
Heads, Directors and VPs of:Data ManagementClinical Operations
Philip Ross (Director, Bristol-Myers Squibb) will be delivering an exciting session on clinical visualisation and the creation of a Data Lake. Is this another step in the evolution of clinical development? Philip is due to address the challenges arising from the need to access and integrate data during clinical studies. He will demonstrate the use of data to support clinical decisions and give examples of the impact of a Data Lake in support of Clinical Program decision making.
A big leap in the evolution of data management was accomplished by switching from paper to electronic systems. Although this transition is still occurring, new systems are proving to benefit pharmaceutical companies in all stages of data analysis and risk monitoring. To carry out successful clinical trials in an industry with growing costs, we must look to incorporate new ways of thinking into advanced monitoring processes. Risk based monitoring involves a systematic ...
Wearable technology is constantly undergoing rapid changes due to constant advancements in all fields. The clinical trial industry is one that can gain beneficial outcomes from technology evolution, notably in terms of efficiency and cost. Whilst many professionals are currently pessimistic about the cost implications of incorporating wearable technology in clinical trials, it is crucial to be mindful that the positives will take time to outweigh the negatives and that ...
‘Good opportunity to collaborate with others companies and to share information.’ Director, Data Management, Advaxis